Caris Life Sciences, Inc. Common Stock (CAI) — Net Asset Quality Index
Caris Life Sciences, Inc. Common Stock (CAI) has a Net Asset Quality Index of 51.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.16 Billion minus total liabilities of $568.90 Million yields net assets of $593.49 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Caris Life Sciences, Inc. Common Stock defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Caris Life Sciences, Inc. Common Stock Net Asset Quality Index Over Time (2003–2025)
This chart shows how Caris Life Sciences, Inc. Common Stock's Net Asset Quality Index has evolved across 22 annual periods from 2003 to 2025. As of March 2026, the index stands at 51.1%, representing net assets of $593.49 Million against total assets of $1.16 Billion USD. Explore Caris Life Sciences, Inc. Common Stock operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Caris Life Sciences, Inc. Common Stock (2003–2025)
The table below presents the year-by-year Net Asset Quality Index for Caris Life Sciences, Inc. Common Stock from 2003 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Caris Life Sciences, Inc. Common Stock market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.3% | $577.31 Million | $1.13 Billion | $548.36 Million | ▲ +778.3 pp |
| 2024 | -727.0% | $-2.50 Billion | $343.73 Million | $2.84 Billion | ▼ -207.5 pp |
| 2023 | -519.5% | $-2.14 Billion | $412.90 Million | $2.56 Billion | ▼ -282.2 pp |
| 2022 | -237.3% | $-1.70 Billion | $717.42 Million | $2.42 Billion | ▼ -264.1 pp |
| 2020 | 26.9% | $702.24 Million | $2.61 Billion | $1.91 Billion | ▲ +3.0 pp |
| 2019 | 23.9% | $693.24 Million | $2.90 Billion | $2.21 Billion | ▲ +0.6 pp |
| 2018 | 23.3% | $701.13 Million | $3.01 Billion | $2.31 Billion | ▲ +0.1 pp |
| 2017 | 23.2% | $563.85 Million | $2.43 Billion | $1.87 Billion | ▲ +0.9 pp |
| 2016 | 22.3% | $457.50 Million | $2.06 Billion | $1.60 Billion | ▼ -1.0 pp |
| 2015 | 23.2% | $461.26 Million | $1.99 Billion | $1.53 Billion | ▼ -1.4 pp |
| 2014 | 24.7% | $442.90 Million | $1.80 Billion | $1.35 Billion | ▼ -0.1 pp |
| 2013 | 24.8% | $415.13 Million | $1.68 Billion | $1.26 Billion | ▼ -0.2 pp |
| 2012 | 25.0% | $346.85 Million | $1.39 Billion | $1.04 Billion | ▼ -1.1 pp |
| 2011 | 26.1% | $248.74 Million | $953.37 Million | $704.63 Million | ▼ -6.1 pp |
| 2010 | 32.2% | $197.67 Million | $613.45 Million | $415.78 Million | ▼ -2.3 pp |
| 2009 | 34.5% | $129.10 Million | $374.08 Million | $244.99 Million | ▲ +6.9 pp |
| 2008 | 27.6% | $113.79 Million | $412.63 Million | $298.84 Million | ▼ -8.9 pp |
| 2007 | 36.5% | $131.15 Million | $359.10 Million | $227.95 Million | ▲ +26.7 pp |
| 2006 | 9.8% | $27.75 Million | $283.00 Million | $255.25 Million | ▼ -8.5 pp |
| 2005 | 18.3% | $32.99 Million | $180.66 Million | $147.67 Million | ▲ +5.2 pp |
| 2004 | 13.1% | $23.82 Million | $181.96 Million | $158.14 Million | ▲ +5.2 pp |
| 2003 | 7.9% | $15.18 Million | $193.10 Million | $177.92 Million | — |